EWTX- Edgewise Therapeutics, Inc.

Name: Edgewise Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Edgewise Therapeutics, Inc. (EWTX) has 15 insiders with recent SEC Form 4 filings, including 5 buys and 23 sells. EWTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Nofi Michael	262.5K	$9.27M	-
Other	Blaustein Robert	105.0K	$3.71M	-
Dir	Martin Christopher Nathan	45.1K	$1.59M	-
CEO	Koch Kevin	38.6K	$1.36M	-
Dir	Morris Arlene	30.0K	$1.06M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 3, 2021	Russell Alan J77	Chief Scientific Officer	Sell	44,172	$17.88	$789,908.90	-7.1%	-28.9%	-47.9%
Oct 15, 2021	Russell Alan J77	Chief Scientific Officer	Sell	7,182	$18.17	$130,482.95	-1.6%	-2.7%	-41.3%
Oct 11, 2021	Russell Alan J77	Chief Scientific Officer	Sell	1,270	$18.02	$22,885.40	-0.8%	+6.5%	-40.6%
Oct 8, 2021	Russell Alan J77	Chief Scientific Officer	Sell	21,028	$18.39	$386,742.62	-4.2%	-0.7%	-45.6%
Oct 5, 2021	Russell Alan J77	Chief Scientific Officer	Sell	5,778	$18.24	$105,409.04	-1.1%	-10.3%	-42.1%
Sep 29, 2021	Russell Alan J77	Chief Scientific Officer	Sell	26,454	$17.10	$452,483.04	-4.6%	-11.8%	-43.5%
Sep 27, 2021	Russell Alan J77	Chief Scientific Officer	Sell	58,546	$18.30	$1,071,421.94	-5.0%	-19.7%	-47.1%
Mar 30, 2021	Flynn James E62	10% Owner, Possible Member Of 10% Group	Buy	625,000	$16.00	$10,000,000.00	+18.9%	-23.8%	-70.3%
Mar 30, 2021	Orbimed Advisors LLC67	Director, 10% Owner	Buy	359,375	$16.00	$5,750,000.00	+2.7%	-23.8%	-70.3%
Mar 30, 2021	Thompson Peter A.65	Director, 10% Owner	Buy	359,375	$16.00	$5,750,000.00	+2.7%	-23.8%	-70.3%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC